Patent applications and USPTO patent grants for Amylin Pharmaceuticals, LLC.The latest application filed is for "sustained release formulations using non-aqueous carriers".
Patent | Date |
---|---|
Sustained Release Formulations Using Non-aqueous Carriers App 20200405815 - Houchin; Mary L. ;   et al. | 2020-12-31 |
Methods For Treating Diabetes And Reducing Body Weight App 20200222509 - Fineman; Mark ;   et al. | 2020-07-16 |
Engineered Polypeptides Having Enhanced Duration Of Action With Reduced Immunogenicity App 20180344813 - ERICKSON; Mary ;   et al. | 2018-12-06 |
Methods For Treating Diabetes And Reducing Body Weight App 20180333468 - FINEMAN; Mark ;   et al. | 2018-11-22 |
Sustained Release Formulations Using Non-aqueous Carriers App 20180271946 - HOUCHIN; Mary L. ;   et al. | 2018-09-27 |
Methods for treating diabetes and reducing body weight Grant 9,884,092 - Fineman , et al. February 6, 2 | 2018-02-06 |
Engineered Polypeptides Having Enhanced Duration Of Action App 20170114114 - Erickson; Mary ;   et al. | 2017-04-27 |
Engineered polypeptides having enhanced duration of action Grant 9,593,154 - Erickson , et al. March 14, 2 | 2017-03-14 |
Glp-1 Receptor Agonist Compounds For Obstructive Sleep Apnea App 20160361390 - Van Cauter; Eve | 2016-12-15 |
Sustained Release Formulations Using Non-aqueous Carriers App 20160346357 - HOUCHIN; Mary L. ;   et al. | 2016-12-01 |
Hybrid polypeptides with selectable properties Grant 9,453,063 - Levy , et al. September 27, 2 | 2016-09-27 |
Methods For Treating Diabetes And Reducing Body Weight App 20160271225 - FINEMAN; Mark ;   et al. | 2016-09-22 |
Engineered polypeptides having enhanced duration of action with reduced immunogenicity Grant 9,382,304 - Erickson , et al. July 5, 2 | 2016-07-05 |
Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent App 20160120950 - Jennings; Robert N. ;   et al. | 2016-05-05 |
Formulation delivery device Grant 9,248,240 - Casey , et al. February 2, 2 | 2016-02-02 |
C-terminal amidation of polypeptides Grant 9,249,181 - Sun , et al. February 2, 2 | 2016-02-02 |
Polymer-based sustained release device Grant 9,238,076 - Wright , et al. January 19, 2 | 2016-01-19 |
GLP-1 receptor agonist compounds having stabilized regions Grant 9,217,022 - Alfaro-Lopez , et al. December 22, 2 | 2015-12-22 |
GLP-1 receptor agonists for islet cell transplantation Grant 9,161,953 - Osei October 20, 2 | 2015-10-20 |
Glp-1 Receptor Agonist Compounds For Obstructive Sleep Apnea App 20150258177 - Van Cauter; Eve | 2015-09-17 |
GIP analog and hybrid polypeptides with selectable properties Grant 9,133,260 - Levy , et al. September 15, 2 | 2015-09-15 |
Exendins To Lower Cholesterol And Triglycerides App 20150238568 - Fineman; Mark ;   et al. | 2015-08-27 |
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20150231204 - LEVY; Odile Esther ;   et al. | 2015-08-20 |
Insulin-pramlintide Compositions And Methods For Making And Using Them App 20150174209 - Chiquette; Elaine ;   et al. | 2015-06-25 |
Transmucosal Delivery Of Peptides And Proteins App 20150157725 - ONG; John ;   et al. | 2015-06-11 |
Methods To Restore Glycemic Control App 20150152158 - RABINOVITCH; Alex ;   et al. | 2015-06-04 |
Methods For Treating Diabetes And Reducing Body Weight App 20150150948 - FINEMAN; Mark ;   et al. | 2015-06-04 |
Method of lowering cholesterol and triglycerides by administering exendins Grant 9,034,819 - Fineman , et al. May 19, 2 | 2015-05-19 |
Transmucosal Delivery Of Engineered Polypeptides App 20150133373 - Ren; Steven Shijun ;   et al. | 2015-05-14 |
Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent App 20150111824 - JENNINGS; Robert N. ;   et al. | 2015-04-23 |
Site-specific Enzymatic Modification Of Exendins And Analogs Thereof App 20150111246 - Samant; Manoj P. ;   et al. | 2015-04-23 |
Formulations and Uses of Exendins and Exendin Agonist Analogs App 20150080308 - KOLTERMAN; Orville G. ;   et al. | 2015-03-19 |
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility App 20150080307 - YOUNG; Andrew A. ;   et al. | 2015-03-19 |
Sustained Release Formulations Using Non-aqueous Carriers App 20150056285 - HOUCHIN; Mary L. ;   et al. | 2015-02-26 |
Modified exendins and exendin agonists Grant 8,951,962 - Prickett , et al. February 10, 2 | 2015-02-10 |
Use of exendin and analogs thereof to delay or prevent cardiac remodeling Grant 8,946,149 - Anderson , et al. February 3, 2 | 2015-02-03 |
Microcrystalline Y receptor agonists Grant 8,927,687 - Ren January 6, 2 | 2015-01-06 |
Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20140371148 - GHOSH; Soumitra S. ;   et al. | 2014-12-18 |
Method for treating diabetes Grant 8,906,851 - Fineman , et al. December 9, 2 | 2014-12-09 |
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 8,906,849 - Levy , et al. December 9, 2 | 2014-12-09 |
GIP and exendin hybrid polypeptides Grant 8,895,498 - Levy , et al. November 25, 2 | 2014-11-25 |
Sustained release formulations using non-aqueous carriers Grant 8,895,033 - Houchin , et al. November 25, 2 | 2014-11-25 |
Hybrid Polypeptides With Selectable Properties App 20140249299 - Levy; Odile Esther ;   et al. | 2014-09-04 |
Amylin-calcitonin Chimeric Peptides Conjugated To Duration Enhancing Moieties App 20140249076 - Samant; Manoj P. ;   et al. | 2014-09-04 |
Long Duration Dual Hormone Conjugates App 20140221282 - Sun; Chengzao ;   et al. | 2014-08-07 |
Drug delivery device Grant 8,790,314 - Casey July 29, 2 | 2014-07-29 |
Methods To Restore Glycemic Control App 20140206613 - RABINOVITCH; Alex ;   et al. | 2014-07-24 |
Treatment Of Cardiac Arrhythmias App 20140200183 - HATHAWAY; David R. ;   et al. | 2014-07-17 |
Peptide-peptidase inhibitor conjugates and methods of using same Grant 8,759,295 - Ghosh , et al. June 24, 2 | 2014-06-24 |
Methods of treatment using exendin peptides or GLP-1 peptides Grant 8,759,291 - Young , et al. June 24, 2 | 2014-06-24 |
N-terminus Conformationally Constrained Glp-1 Receptor Agonist Compounds App 20140162943 - ALFARO-LOPEZ; Josue ;   et al. | 2014-06-12 |
Methods for affecting body composition using amylin agonists Grant 8,748,375 - Mack , et al. June 10, 2 | 2014-06-10 |
Peptide Yy And Peptide Yy Agonists For Treatment Of Metabolic Disorders App 20140135261 - PITTNER; Richard A. ;   et al. | 2014-05-15 |
Engineered Polypeptides Having Enhanced Duration Of Action App 20140107019 - ERICKSON; Mary ;   et al. | 2014-04-17 |
Methods For Affecting Body Composition App 20140066368 - Mack; Christine Marie ;   et al. | 2014-03-06 |
Polypeptide Conjugate App 20140066370 - Forood; Behrouz Bruce ;   et al. | 2014-03-06 |
Glp-1 Receptor Agonist Compounds For Obstructive Sleep Apnea App 20140056924 - VAN CAUTER; Eve | 2014-02-27 |
Modified Exendins And Exendin Agonists App 20140038891 - Prickett; Kathryn S. ;   et al. | 2014-02-06 |
N-terminus conformationally constrained GLP-1 receptor agonist compounds Grant 8,642,544 - Alfaro-Lopez , et al. February 4, 2 | 2014-02-04 |
Pen injection device and method of using same Grant 8,636,689 - Halili, Jr. , et al. January 28, 2 | 2014-01-28 |
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility App 20130331322 - Young; Andrew A. ;   et al. | 2013-12-12 |
Pancreatic polypeptide family motifs and polypeptides comprising the same Grant 8,603,969 - Levy , et al. December 10, 2 | 2013-12-10 |
GLP-1 receptor agonist bioassay Grant 8,603,761 - Nicolaou , et al. December 10, 2 | 2013-12-10 |
Methods for treatment using amylin family peptides Grant 8,598,120 - Soares , et al. December 3, 2 | 2013-12-03 |
Peptide-peptidase-inhibitor conjugates and methods of making and using same Grant 8,598,314 - Ghosh , et al. December 3, 2 | 2013-12-03 |
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20130303442 - LEVY; Odile Esther ;   et al. | 2013-11-14 |
Microcrystalline Y Receptor Agonists App 20130296225 - Ren; Steven Shijun | 2013-11-07 |
Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties App 20130281374 - Levy; Odile Esther ;   et al. | 2013-10-24 |
Engineered Polypeptides Having Enhanced Duration Of Action App 20130274182 - Erickson; Mary ;   et al. | 2013-10-17 |
Treatment of hibernating myocardium with an exendin peptide Grant 8,551,947 - Coolidge , et al. October 8, 2 | 2013-10-08 |
Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating Disorders App 20130225485 - Weyer; Christian ;   et al. | 2013-08-29 |
Prevention And Treatment Of Cardiac Arrhythmias App 20130209586 - HATHAWAY; David R. ;   et al. | 2013-08-15 |
Highly Soluble Leptins App 20130203661 - Erickson; Mary | 2013-08-08 |
Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen Grant 8,501,693 - Kim , et al. August 6, 2 | 2013-08-06 |
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130196913 - Levy; Odile Esther ;   et al. | 2013-08-01 |
DPP-IV resistant GIP hybrid polypeptides with selectable properties Grant 8,497,240 - Levy , et al. July 30, 2 | 2013-07-30 |
Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis Grant 8,481,490 - Tatarkiewicz , et al. July 9, 2 | 2013-07-09 |
Methods for Treating Diabetes and Reducing Body Weight App 20130172243 - Fineman; Mark ;   et al. | 2013-07-04 |
Exendins To Lower Cholesterol And Triglycerides App 20130172250 - FINEMAN; Mark ;   et al. | 2013-07-04 |
Formulations of Exendins and Exendin Agonist Analogs App 20130165379 - Kolterman; Orville G. ;   et al. | 2013-06-27 |
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130137631 - LEVY; Odile Esther ;   et al. | 2013-05-30 |
Polymer-based Sustained Release Device App 20130130977 - Wright; Steven G. ;   et al. | 2013-05-23 |
Modified exendins and exendin agonists Grant 8,445,647 - Prickett , et al. May 21, 2 | 2013-05-21 |
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 8,426,361 - Levy , et al. April 23, 2 | 2013-04-23 |
Glp-1 Receptor Agonist Bioassay App 20130089878 - Nicolaou; Michalis ;   et al. | 2013-04-11 |
GIP analog and hybrid polypeptides with selectable properties Grant 8,404,637 - Levy , et al. March 26, 2 | 2013-03-26 |
Methods of treating obesity with two different anti-obesity agents Grant 8,394,765 - Roth , et al. March 12, 2 | 2013-03-12 |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease Grant 8,389,472 - Baron , et al. March 5, 2 | 2013-03-05 |
Treatment of cardiac arrhythmias Grant 8,389,473 - Hathaway , et al. March 5, 2 | 2013-03-05 |
Amylin and amylin agonists for treating psychiatric diseases and disorders Grant 8,389,477 - Laugero , et al. March 5, 2 | 2013-03-05 |
Neuromedin and FN-38 Peptides for Psychotic Diseases App 20130035294 - Laugero; Kevin D. ;   et al. | 2013-02-07 |
Methods To Restore Glycemic Control App 20130023471 - Rabinovitch; Alex ;   et al. | 2013-01-24 |
Exendin And Exendin Agonists For Eating Disorders App 20130023470 - Young; Andrew A. ;   et al. | 2013-01-24 |
Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders App 20130023466 - PITTNER; Richard A. ;   et al. | 2013-01-24 |
GLP-1 receptor agonist bioassays Grant 8,329,419 - Nicolaou , et al. December 11, 2 | 2012-12-11 |
Methods for treating diabetes and reducing body weight Grant 8,329,648 - Fineman , et al. December 11, 2 | 2012-12-11 |
Neuromedin and FN-38 peptides for treating psychiatric diseases Grant 8,309,522 - Laugero , et al. November 13, 2 | 2012-11-13 |
Methods to restore glycemic control Grant 8,299,024 - Rabinovitch , et al. October 30, 2 | 2012-10-30 |
Exendin and exendin agonists for eating disorders Grant 8,288,338 - Young , et al. October 16, 2 | 2012-10-16 |
Method of modifying food preference comprising administering amylin or amylin agonist Grant 8,278,267 - Weyer , et al. October 2, 2 | 2012-10-02 |
Methods of treating obesity using PYY[3-36] Grant 8,273,713 - Pittner , et al. September 25, 2 | 2012-09-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.